Evidence map›Paper›PMID 39416772›Full record

ArticleDrugs in context2024

Multidisciplinary and personalized approach to the management of mycosis fungoides with chlormethine gel: a collection of clinical experiences.

Silvia Alberti Violetti, Marco Ardigò, Paolo Fava, Giuseppe Gritti, Erika Morsia, Francesco Onida, Marco Paulli, Alessandro Pileri, Pietro Quaglino, Serena Rupoli and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Drugs in context, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Silvia Alberti Violetti *Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Marco Ardigò *Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.
Paolo Fava *Department of Medical Sciences, Dermatology Section, University of Turin, Turin, Italy.
Giuseppe Gritti *Hematology and BMT Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
Erika Morsia *Hematology Department, University of Ancona, Azienda Ospedaliera Universitaria Ospedali Riuniti di Ancona, Ancona, Italy.
Francesco Onida *Hematology and BMT Unit, ASST Fatebenefratelli-Sacco - University of Milan, Italy.
Marco Paulli *Unità di Anatomia Patologica, Dipartimento di Medicina Molecolare, Università degli Studi di Pavia, Pavia, Italy.
Alessandro Pileri *Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Pietro Quaglino *Department of Medical Sciences, Dermatology Section, University of Turin, Turin, Italy.
Serena Rupoli *Hematology Department, University of Ancona, Azienda Ospedaliera Universitaria Ospedali Riuniti di Ancona, Ancona, Italy.
Miriam Teoli *Porphyria and Rare Diseases Unit, San Gallicano Dermatological Institute - IRCCS, via Chianesi 53, 00144 Rome, Italy.ORCID https://orcid.org/0000-0002-7690-7771
Pamela Vezzoli *Dermatology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Topical chlormethine (CL) gel formulation was approved by the EMA in 2017 for the treatment of adult patients with mycosis fungoides (MF). To expand the knowledge on the management of MF, this paper provides an overview of clinical practice evidence about the MF diagnostic phase and a collection of clinical experiences to better characterize the use of CL gel in daily practice. Collected cases underline the importance of the concomitant biopsy and clinical evaluation in the diagnostic phase, with the contribution of a multidisciplinary team, and support the use of CL gel as a first-line or adjuvant treatment in selected patients.

Indexed as

chlormethine gelcutaneous T cell lymphomamycosis fungoides

Identifiers

PMID39416772
PMCPMC11482090

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.